Xiaorong Wang

Key Laboratory Of Drug Targeting And Drug Delivery System Of The Education Ministry And Sichuan Province
Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Challenges and strategies for nose-to-brain delivery in treating neurological disorders.

Challenges and strategies for nose-to-brain delivery in treating neurological disorders.

Journal: Expert opinion on drug delivery

Published: November 03, 2025

Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease.

Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease.

Journal: Acta pharmaceutica Sinica. B

Published: September 22, 2024

Lysosome-Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano-Chimera for AD Therapy.

Lysosome-Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano-Chimera for AD Therapy.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: July 29, 2024

Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator.

Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator.

Journal: Acta pharmaceutica Sinica. B

Published: March 01, 2024

Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting.

Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 30, 2024

Mannose-Integrated Nanoparticle Hitchhike Glucose Transporter 1 Recycling to Overcome Various Barriers of Oral Delivery for Alzheimer's Disease Therapy.

Mannose-Integrated Nanoparticle Hitchhike Glucose Transporter 1 Recycling to Overcome Various Barriers of Oral Delivery for Alzheimer's Disease Therapy.

Journal: ACS nano

Published: January 12, 2024

Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer's Disease.

Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer's Disease.

Journal: Research (Washington, D.C.)

Published: January 26, 2023

Hsp70-Targeting and Size-Tunable Nanoparticles Combine with PD-1 Checkpoint Blockade to Treat Glioma.

Hsp70-Targeting and Size-Tunable Nanoparticles Combine with PD-1 Checkpoint Blockade to Treat Glioma.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: January 19, 2023

Chondroitin sulfate-based prodrug nanoparticles enhance photodynamic immunotherapy via Golgi apparatus targeting.

Chondroitin sulfate-based prodrug nanoparticles enhance photodynamic immunotherapy via Golgi apparatus targeting.

Journal: Acta biomaterialia

Published: February 09, 2022

Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection.

Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection.

Journal: Acta pharmaceutica Sinica. B

Published: November 18, 2021

Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.

Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.

Journal: Journal of oncology

Published: January 12, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026